Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-04-09

FDA Approved: OXCARBAZEPINE — Original Application (Advagen Pharma Limited)

View source ↗

Summary

The FDA approved Advagen Pharma Limited's original ANDA for oxcarbazepine, a generic anticonvulsant.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxcarbazepine (Oxcarbazepine)

Snippet

ORIG AP for OXCARBAZEPINE (OXCARBAZEPINE)